| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-16 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-15 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-11 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.29 | 9e-10 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |